ClearMed
All Gastroenterology BriefingsHepatology (baltimore, Md.)
GastroenterologyReal-World Cohort3 min read

ATTEST 2027: A Framework for AI Transparency Tiered by Evidentiary Stakes

Within this tiered system, we propose minimum reporting standards by function, cross-cutting requirements, and obligations for reviewers and editors.

Published in Hepatology (baltimore, Md.)Observational cohort study
3/5 Observational
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Source

Real-World Observation

3/5

The goal is to make AI's role in evidence generation transparent to readers, reviewers, and editors so they can evaluate the integrity of scientific findings.

What Changes?

Gastroenterology · Real-World Cohort

Current Standard

Conventional gastroenterology practice relies on standard-of-care monitoring and existing regimens prior to this observational cohort study.

New Finding

The framework is operationalized by a declaration checklist that authors complete at submission.

3 Key Takeaways

Plain English Summary
  1. 01Core Finding

    Scientific journals and professional organizations agree that authors should disclose AI assistance.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

What This Means for You

The framework is operationalized by a declaration checklist that authors complete at submission. Within this tiered system, we propose minimum reporting standards by function, cross-cutting requirements, and obligations for reviewers and editors. The goal is to make AI's role in evidence generation transparent to readers, reviewers, and editors so they can evaluate the integrity of scientific findings.

The Discovery

Artificial intelligence (AI) is now being used across scientific research workflows, from data extraction and code generation to literature synthesis and manuscript drafting. Scientific journals and professional organizations agree that authors should disclose AI assistance. But disclosure that treats all AI use equally with a single generic declaration reveals little about the nature of AI's influence on evidence generation. Polishing grammar carries a different risk than extracting outcomes from clinical notes, classifying pathology, or making causal inference. We propose ATTEST (AI Transparency Tiered by Evidentiary Stakes), a framework that evaluates AI assistance by its consequences. ATTEST classifies AI use into eight broad categories of functions, each scored at one of four risk tiers (Low, Medium, High, Very High).

How It Works, Simply

This gastroenterology research focuses on AI model. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.

3 Key Takeaways

Clinical Takeaways
  1. 01Core Finding

    Scientific journals and professional organizations agree that authors should disclose AI assistance.

  2. 02Study Evidence

    Tested in a observational cohort study at the real-world cohort stage.

  3. 03Practical Meaning

    Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

01

Biological Mechanism & Study Design

Study Design & Cohort

Observational cohort study

Observational cohort study · Real-World Cohort

Biological Pathway & Modality

AI model

Intervention: ATTEST 2027: A Framework for AI Transparency Tiered by Evidentiary Stakes

02

Experimental Findings & Endpoints

Artificial intelligence (AI) is now being used across scientific research workflows, from data extraction and code generation to literature synthesis and manuscript drafting.

Scientific journals and professional organizations agree that authors should disclose AI assistance. But disclosure that treats all AI use equally with a single generic declaration reveals little about the nature of AI's influence on evidence generation.

Polishing grammar carries a different risk than extracting outcomes from clinical notes, classifying pathology, or making causal inference. We propose ATTEST (AI Transparency Tiered by Evidentiary Stakes), a framework that evaluates AI assistance by its consequences.

ATTEST classifies AI use into eight broad categories of functions, each scored at one of four risk tiers (Low, Medium, High, Very High).

03

Clinical Translation & Practice Context

The framework is operationalized by a declaration checklist that authors complete at submission.

Within this tiered system, we propose minimum reporting standards by function, cross-cutting requirements, and obligations for reviewers and editors. The goal is to make AI's role in evidence generation transparent to readers, reviewers, and editors so they can evaluate the integrity of scientific findings.

03

The Bottom Line · Clinical Pearl

“The goal is to make AI's role in evidence generation transparent to readers, reviewers, and editors so they can evaluate the integrity of scientific findings.”

Published in Hepatology (baltimore, Md.) · Current Stage: Real-World Cohort

Gastroenterology · Real-World Cohort
Study Type
Observational cohort study

Observational cohort study

Evidence Score
3/5 · Real-World Observation
Evidence Meter · 3/5

Real-World Observation

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Finds meaningful patterns in human health records or cohorts, though observational data cannot prove direct cause.

Who It Applies To
Observational cohort study in gastroenterology care
Intervention & Mechanism
ATTEST 2027: A Framework for AI Transparency Tiered by Evidentiary Stakes

AI model

Key Limitation
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.

Translational Stage

LEVEL 2 · Real-World Cohort

Classified as Observational cohort study along the clinical evidence continuum

  1. Lab & Discovery
  2. Early Trials
  3. Human Evidence
  4. 4Real-World CohortActive

Indexed Clinical Entities

Original Publication & AMA Citation

ATTEST 2027: A Framework for AI Transparency Tiered by Evidentiary Stakes. Hepatology (baltimore, Md.). Published 2026;Nov 5. Accessed November 15, 2026. https://pubmed.ncbi.nlm.nih.gov/42992833/

Hepatology (baltimore, Md.)

https://pubmed.ncbi.nlm.nih.gov/42992833/

Read Original Paper

Continue Reading

Related in Gastroenterology

View all Gastroenterology briefings →
GASTROENTEROLOGY · REAL-WORLD COHORT

Prevalence of liver fibrosis and steatotic liver disease in community-dwelling adults in China (the CHESS-LiverHealth project): cross-sectional baseline data from a prospective cohort study

Silent Liver Damage: A Hidden Epidemic in China's Adult Population. Liver scarring and fatty liver disease are widespread among Chinese adults, largely fueled by metabolic issues and alcohol.

4/5 Strong Trial
Evidence Meter · 4/5

Strong Clinical Evidence

Tested directly in patients through a prospective clinical trial or large multicenter human cohort.

1 min readThe Lancet Gastroenterology & Hepatology
Gastroenterology editorial photograph for Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial
GASTROENTEROLOGY · PHASE III

Aspirin after curative-intent treatment of colorectal cancer liver metastases (ASAC): a multicentre, phase 3, randomised, double-blind, placebo-controlled trial

Aspirin After Colon Cancer: A Surprising Setback for a Common Drug. Taking aspirin after surgery for colon cancer that spread to the liver did not prevent the cancer from returning and was linked to worse survival and more serious side effects.

5/5 Gold Standard
Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readThe Lancet Gastroenterology & Hepatology
GASTROENTEROLOGY · REAL-WORLD COHORT

Genetic variants and the risk of renal impairment in decompensated cirrhosis: a multi-ancestry genome-wide association study

Unlocking the Genetic Link Between Liver Failure and Kidney Damage. Scientists have pinpointed a specific gene, SUSD1, that significantly increases the risk of kidney problems in people with severe liver disease.

5/5 Gold Standard
Evidence Meter · 5/5

Gold-Standard Human Evidence

Backed by randomized controlled human trials or a formal meta-analysis pooling multiple clinical studies.

1 min readThe Lancet Gastroenterology & Hepatology